Immunotherapy Development Strategies

JSB Market Research : Immunotherapy Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome
Immunotherapy.jpg
Although immunotherapy was first recognized over 100 years ago, it has only become an important therapeutic tool in recent decades. The immune system can be harnessed in one of several ways to tackle various diseases such as cancer, infection, auto-immune disease and inflammatory diseases.

The complexity of the immune system has led to some intrinsic obstacles with clinical research, particularly in relation to targeting the right genes, identifying the appropriate patient population and accessing internal tissues for testing.

Market access presents a significant hurdle for immunotherapeutics, as many are high cost and do not deliver the measurements required for traditional cost-effectiveness assessments.

Oncology has been a primary area of focus for immunotherapeutics, largely due to the potential offered by this market but also due to the critical role the immune system plays in the proliferation of cancer throughout the body. Auto-immune and inflammatory diseases are also attractive targets for immunotherapy, with several different approaches being investigated.

The report, Immunotherapy Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome was written to support executives within both the commercial and R&D sides of the biopharmaceutical industry. It provides key insights through the analysis of issues, trends, and the future outlook of immunological therapies to support executive decision making for both biotech and pharmaceuticals companies alike.

Scope

Immunotherapy Overview
Immunotherapeutic Development and Launch Strategies
Trends in the Development of Immunotherapeutics
The Immunotherapeutics Market
Key Companies Involved in Immunotherapeutics
Case Studies
Future outlook

Browse Full Report@ http://www.jsbmarketresearch.com/healthcare-medical/r-Immunotherapy-Development-Strategies-25045

Key Reasons to Purchase

Access CBRs insights and analysis on the opportunities which exist within this complicated and fast moving market
Better understand where both the main opportunities and challenges exist to successfully developing an immunotherapeutic product and what it will take to get there

Gain a more complete picture of the where the trends in development are taking the future of immunotherapeutics
Utilize CBRs case study analysis to help support key business decisions
Benefit from CBRs identification and discussion on the lessons learned when developing an immunotherapeutic product and our outlook on the future of the market

Discounts on Market Research Reports till 28 February, 2015

http://www.jsbmarketresearch.com/discount.php

For more inquiries, contact at +91 - 998 729 5242 /contact@jsbmarketresearch.com

Table of Contents

Executive summary
Methodology
Immunotherapy Overview
History
Key technologies
Immunotherapeutic Development and Launch Strategies
Early stage research
Clinical trial design
Regulatory considerations
Market access
Case study - Provenge
Trends in the Development of Immunotherapeutics
Oncology is the current focus
Other diseases being researched
Multiple Sclerosis
Allergy
Alzheimers Disease
The Immunotherapeutics Market
Market forecast
Key Companies Involved in Immunotherapeutics
Lessons learned from past failures : Case studies
Future Outlook
Appendix

For More Related Market Research Reports click here:

http://www.jsbmarketresearch.com/healthcare-medical/r-RD-Productivity-State-Research-Development-BioPharmaceutical-Industry-25042

http://www.jsbmarketresearch.com/healthcare-medical/r-Companion-Diagnostics-Streamlining-drug-development-25043

http://www.jsbmarketresearch.com/healthcare-medical
Name
Email
Comment
Or visit this link or this one